ourlyard glp-1 Genuinely don’t know what I’m meant to do to stop my name being used to ‘endorse’ shonky products. This clearly isn’t endorsed by me. The Guardian wrote an article about this problem, the rise in RACGP - Is the first

patients who did not work with a Nourish RD 60% of Nourish patients who discontinued GLP-1s found Nourish helpful in maintaining their weight post-treatment Nourish programs drive meaningful cost savings for employers ($2.1M for an employer with 10K employees) by avoiding wasted spend and optimizing for greater results These outcomes show that pairing GLP-1 treatment with personalized, insurance-covered nutrition care from Nourish makes a measurable difference in long-term results

Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial

[DOI] [PMC free article] [PubMed] [Google Scholar] 501.Konkov, L

PEIA opted to pause the program in 2024 citing a $1.3 million per month price tag, inclusive of rebates

The self-insured part of the employer market is more likely to cover GLP-1s, since employers may feel pressure to cover the medications, and because the tenure of workers is generally longer in larger self-insured companies

If less than three days remain before the next dose is due then the missed dose should be skipped, and the next dose administered on the usual scheduled day